Improvita Successfully Completes Human Factors Validation Program Supporting Beyond Air’s LungFit® PH FDA Approval
August 16, 2022MADISON, Wis., Aug. 16, 2022 /PRNewswire/ — Improvita, Inc., a Madison-based company affiliated with Innovenn, Inc., that focuses on human factors testing, ethnographic field research, user interface testing, and user experience testing for medical devices, software as a medical device, and combination drug / medical device products, is celebrating the approval of Beyond Air’s LungFit® PH […]Improvita celebrates first anniversary with an innovative pivot in response to the global pandemic
September 30, 2020Improving patient healthcare through Innovation MADISON, Wisc., September 24, 2020 — One year ago, Innovenn, a leader in Digital Therapeutics, separated its human factors testing business under a new name: Improvita, which means ‘To Improve Life’. Improvita focuses on human factors testing, ethnographic research, user interface testing, and user experience testing for medical devices, software […]
Improvita Successfully Completes Human Factors Validation Program Supporting Beyond Air’s LungFit® PH FDA Approval
August 16, 2022
MADISON, Wis., Aug. 16, 2022 /PRNewswire/ — Improvita, Inc., a Madison-based company affiliated with Innovenn, Inc., that focuses on human factors testing, ethnographic field research, user interface testing, and user experience testing for medical devices, software as a medical device, and combination drug / medical device products, is celebrating the approval of Beyond Air’s LungFit® PH […]
Improvita celebrates first anniversary with an innovative pivot in response to the global pandemic
September 30, 2020
Improving patient healthcare through Innovation MADISON, Wisc., September 24, 2020 — One year ago, Innovenn, a leader in Digital Therapeutics, separated its human factors testing business under a new name: Improvita, which means ‘To Improve Life’. Improvita focuses on human factors testing, ethnographic research, user interface testing, and user experience testing for medical devices, software […]
